Answers are grounded in this paper and cite their sources.
Reactive oxygen species (ROS) and immune response play critical roles in the progression of liver diseases. DJ-1, also known as Parkinson disease 7 (Park7), is extensively expressed in cells and tissues, where it governs numerous biological functions including chaperone activity, protease function, transcriptional and mitochondrial regulation, and ROS modulation. Moreover, we have established that DJ-1 plays a critical role in initiating an inflammatory response by modulating ROS generation. Therefore, DJ-1 may play an important role in the progression of liver diseases by modulating ROS and the immune response. Recently, we have shown that DJ-1 deficiency negatively regulates proliferation of hepatic progenitor cells (HPCs) by impairing the formation of HPC-associated fibrosis and inflammatory niches. Deficiency of DJ-1 ameliorates liver fibrosis by inhibiting hepatic ROS production and inflammation; moreover, in a classic diethylnitrosamine (DEN)-mediated hepatocellular carcinoma (HCC) mouse model, deletion of DJ-1 ameliorates tumorigenesis and HCC cell proliferation by regulating hepatic inflammation and reducing the activity of the interleukin 6/signal transducer and activator of transcription 3 (IL-6/STAT3) signaling pathway. Taken together, these data suggest a critical function for, and therapeutic value of, DJ-1 in treatment of liver diseases. The aim of this review is to summarize these functions and the underlying molecular mechanisms of DJ-1 in liver diseases, and to highlight the potential therapeutic value and future research direction of DJ-1 in liver diseases.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: